BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24406621)

  • 1. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
    Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
    Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of TFDP3 on regulating the autophagy and apoptosis of LNCaP cells].
    Ren LF; Ma YY; Yue QH; Su MQ; Hao XK
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):347-9. PubMed ID: 22482402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFDP3 inhibits E2F1-induced, p53-mediated apoptosis.
    Tian C; Lv D; Qiao H; Zhang J; Yin YH; Qian XP; Wang YP; Zhang Y; Chen WF
    Biochem Biophys Res Commun; 2007 Sep; 361(1):20-5. PubMed ID: 17632080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
    Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
    Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
    Ding LY; Chu M; Jiao YS; Hao Q; Xiao P; Li HH; Guo Q; Wang YD
    PLoS One; 2018; 13(9):e0203833. PubMed ID: 30235236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
    Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
    Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.
    Jiao Y; Ding L; Chu M; Wang T; Kang J; Zhao X; Li H; Chen X; Gao Z; Gao L; Wang Y
    PLoS One; 2017; 12(8):e0182781. PubMed ID: 28797103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
    Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
    Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
    Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis.
    Libertini SJ; Tepper CG; Guadalupe M; Lu Y; Asmuth DM; Mudryj M
    Prostate; 2006 Jan; 66(1):70-81. PubMed ID: 16114066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.
    Mitomi H; Fukui N; Kishimoto I; Tanabe S; Kikuchi S; Saito T; Hayashi T; Yao T
    Hum Pathol; 2011 Oct; 42(10):1505-13. PubMed ID: 21496871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
    Yin H; Lowery M; Glass J
    Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
    Orjuela M; Orlow I; Dudas M; Ponce-CastaƱeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
    Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
    Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M; Hacohen D; Ginsberg D
    Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.